Results 211 to 220 of about 19,870 (257)
Some of the next articles are maybe not open access.

Dilated cardiomyopathy

The Lancet, 2010
Dilated cardiomyopathy is characterised by left ventricular dilation that is associated with systolic dysfunction. Diastolic dysfunction and impaired right ventricular function can develop. Affected individuals are at risk of left or right ventricular failure, or both. Heart failure symptoms can be exercise-induced or persistent at rest.
John Lynn, Jefferies, Jeffrey A, Towbin
openaire   +2 more sources

Dilated cardiomyopathy

Current Opinion in Cardiology, 1994
The etiology and pathogenesis of dilated cardiomyopathy continues to be controversial. The importance of viral and familial etiologies is becoming increasingly recognized. Molecular biology will add significantly to our understanding of these factors in the near future.
S C, Siu, M J, Sole
openaire   +2 more sources

Immunoadsorption in dilated cardiomyopathy

Transfusion and Apheresis Science, 2007
Dilated cardiomyopathy (DCM) is a common myocardial disease characterized by ventricular dilatation and progressive depression of myocardial contractile function. Disturbances in both humoral and cellular immunity have been described among these patients. A number of antibodies against various cardiac cell proteins have been identified in DCM.
Alexander, Staudt, Stephan B, Felix
openaire   +2 more sources

Alcoholic dilated cardiomyopathy

Nursing Standard, 2008
This article provides an overview of alcoholic dilated cardiomyopathy. It aims to increase awareness of the condition among nurses, and help in early diagnosis and appropriate treatment referrals. The key message is that all patients with alcoholic dilated cardiomyopathy should be advised and assisted to stop drinking alcohol.
Anna, Adam   +2 more
openaire   +2 more sources

MYOCARDITIS AND DILATED CARDIOMYOPATHY

Annual Review of Medicine, 1987
The recent developments in the study of myocarditis and dilated cardiomyopathy are reviewed here, with the primary emphasis on the issue of myocarditis as a precursor to dilated cardiomyopathy. Advances in immunologic approaches have expanded our knowledge of the course of myocarditis, experimentally as well as clinically.
C, Kawai, A, Matsumori, H, Fujiwara
openaire   +2 more sources

Immunopathogenesis of dilated cardiomyopathies

Current Opinion in Cardiology, 1995
Idiopathic dilated cardiomyopathy is a chronic heart muscle disorder of unknown etiology, but experimental and clinical evidence is accumulating that points to an immune pathogenesis in a subset of patients, and to the potential importance of myosin as an antigen. Most recent developments include evidence of cardiac- and disease-specific autoantibodies
J H, Goldman, W J, McKenna
openaire   +2 more sources

Dilated cardiomyopathy

Current Treatment Options in Cardiovascular Medicine, 2001
The management of patients with dilated cardiomyopathy (DCM) heart failure starts with the determination of the underlying diagnosis, definition of the hemodynamic character (eg, systolic, diastolic, valvular, right- and left-sided heart dysfunction), recognition of complicating factors (eg, atrial fibrillation, renal dysfunction), and consideration ...
openaire   +2 more sources

Dilated cardiomyopathy

European Heart Journal, 1984
On account of the rapidly progressive nature of the disease, the high incidence of systemic embolism and arrhythmias, and the risk of sudden death, dilated cardiomyopathy is inconsistent with aircrew duties. In the small proportion of subjects who apparently make a satisfactory recovery , re-licensing may be considered once there is no requirement for ...
openaire   +2 more sources

Idiopathic Dilated Cardiomyopathy

New England Journal of Medicine, 1994
G William Dec   +2 more
exaly   +3 more sources

Anaphylatoxins in dilated cardiomyopathy

Journal of Internal Medicine, 1993
Abstract. Objects. The aim of the study was to investigate the possible relationship between activation of complement system and thromboembolic complications in dilated cardiomyopathy (DCMP).Methods. The plasma C3a and C5a concentrations were determined by radioimmunoassay measurement (Amersham International, UK) in 23 patients with DCMP, 9 with ...
M, Samsonov   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy